Image

Home Blood Pressure Telemonitoring LINKED With Community Health Workers to Improve Blood Pressure

Home Blood Pressure Telemonitoring LINKED With Community Health Workers to Improve Blood Pressure

Non Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The LINKED-BP Program is a patient-centered, multi-level intervention linking home blood pressure monitoring (HBPM) with a telemonitoring platform (Sphygmo) that links with all Bluetooth-enabled validated blood pressure (BP) devices, support from community health workers (CHWs), and BP measurement training at community health centers serving high-risk adults to prevent stage 2 hypertension (BP ≥ 140/90 mm Hg). The LINKED-BP Program study will recruit a total of 600 adults (30 from each practice) with elevated BP (120-129/<80 mm Hg) or untreated stage 1 hypertension (130-139/80-89 mm Hg) across 20 community health centers or primary care practices serving high-risk adults. This cluster-randomized trial consists of two arms: (1) enhanced "usual care arm," wherein patients will be provided with Omron 10 series home BP monitors (HBPM) and will be managed by the patients' primary care clinicians as usual; and (2) the LINKED-BP Program or "intervention arm," which will include training of patients on HBPM, Sphygmo BP telemonitoring app, and CHW visits for education and counseling on lifestyle modification. The intervention period for each study participant is 12 months.

Eligibility

Inclusion Criteria:

  • 18 years of age as of the date of data extraction
  • Self-identify as non-Hispanic white, non-Hispanic African-American or Hispanic
  • Have elevated BP (120-129/<80 mm Hg) or untreated stage 1 hypertension (130-139/80-89 mm Hg) (defined by AHA's 2017 hypertension clinical guidelines)
  • Receives primary medical care at one of the participating community health centers and primary care practices

Exclusion Criteria:

  • Age <18 years
  • Prescribed antihypertensive medication
  • Diagnosis of end-stage renal disease (ESRD)
  • Condition which interferes with outcome measurement (e.g., dialysis)
  • Serious medical condition which either limits life expectancy or requires active management (e.g., cancer)
  • Patients with serious cognitive impairment or other conditions preventing their participation in the intervention
  • Upper arm circumference >50 cm (maximum limit of the extra-large BP cuff)
  • Those planning to leave the practice or move out of the geographic area in 18 months
  • Those who no longer consider the practice site the location where they receive primary care
  • Unwillingness to provide informed consent

Study details
    Hypertension
    High Blood Pressure

NCT05180045

Johns Hopkins University

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.